Rachael Busch, NP
Family · Loxahatchee, FLNPI 1063819589
Payments from drug & device makers
Across 1,202 payments — averaging $157.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$50K
- Amgen$44K
- Johnson & Johnson$23K
- Pfizer$17K
- Boehringer Ingelheim$15K
- AstraZeneca$9K
- plus $30K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 129 | $50,312 |
| Amgen(2 entities) | 209 | $44,337 |
| Johnson & Johnson(2 entities) | 90 | $23,450 |
| Pfizer | 76 | $17,114 |
| Boehringer Ingelheim | 52 | $14,504 |
| AstraZeneca(2 entities) | 80 | $9,066 |
| ANI Pharmaceuticals, Inc. | 66 | $6,128 |
| UCB, Inc. | 125 | $4,817 |
| Sobi, Inc | 16 | $4,573 |
| Lilly USA, LLC | 28 | $4,532 |
| Novartis | 102 | $3,253 |
| Janssen Scientific Affairs, LLC | 8 | $1,509 |
| AbbVie | 58 | $1,278 |
| Sanofi | 17 | $793 |
| GSK | 36 | $707 |
| E.r. Squibb & Sons, L.L.C. | 22 | $327 |
| Radius Health, Inc. | 14 | $272 |
| Kyowa Kirin, Inc. | 7 | $226 |
| Actelion Pharmaceuticals US, Inc. | 6 | $199 |
| Recordati_rare_diseases_inc. | 6 | $173 |
| Aurinia Pharma U.S., Inc. | 8 | $155 |
| Fresenius Kabi USA, LLC | 7 | $153 |
| Scilex Pharmaceuticals Inc. | 6 | $133 |
| Alvogen Inc | 5 | $106 |
| Neurometrix Inc | 1 | $100 |
| Genentech USA, Inc. | 5 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| Organon | 8 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $55 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $43 |
| Invivyd Inc | 2 | $34 |
| Vertex | 1 | $30 |
| Abbott | 1 | $23 |
| Mylan Institutional Inc. | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| ADMA Biomanufacturing LLC | 1 | $20 |
| Almatica Pharma LLC | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
How this compares
$188,760 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Loxahatchee
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.